Research shows that men with prostate cancer have a significantly reduced risk for death if they took statins prior to their diagnosis.

Study results add further support to the use of circulating tumor cells as an effective prognostic marker in prostate cancer, and suggest that they could be used to monitor metastatic disease progression.

A study of US servicemen shows that, despite being eligible for active surveillance, the overwhelming majority of young men diagnosed with very-low-risk prostate cancer opt for immediate treatment.

Men should be warned that the chances of harm from screening with the prostate-specific antigen test outweigh the likelihood of benefit for most men, says the American College of Physicians in a guideline statement on prostate cancer screening.

Determining the androgen content in prostate tissue could predict patients’ responses to androgen deprivation therapy and the risk for castration-resistant prostate cancer, show study findings.

Researchers have confirmed that the prostate cancer gene 3 is a valid predictor for current cancer and future biopsy outcomes.

A significant proportion of patients with prostate cancer who are treated with brachytherapy develop gross hematuria years later, report researchers.

Men who eat deep-fried food at least once a week may be increasing their risk for developing prostate cancer, show findings from a US study.